EdenRoc Sciences LLC
Worcester, MA · Founded 2016 · CIK 0001685567 · Biotech · Private
Biotech research and development platform for therapeutic discovery
edenrocsciences.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $194M
- 10 Form D · Nov 2024
- 23 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $30,000,000 | |
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $13,500,000 | |
| Private capital raised | Form D · SEC | $8,000,000 | |
| Private capital raised | Form D · SEC | $17,600,000 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $18,000,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $19,100,016 | |
| Private capital raised | Form D · SEC | $55,525,000 | |
| Private capital raised | Form D · SEC | $2,750,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2272 | CISTERNA BIOLOGICS, INC. | — | — |
| 2273 | INPHASOL INC. | — | — |
| 2274 | SYNVEST IMAGING INC. | — | — |
| 2275 | EdenRoc Sciences LLC | — | $194M |
| 2276 | ENGAGE BIOLOGICS INC. | — | — |
| 2277 | Perfect Day, Inc. | — | $222M |
| 2278 | Dren Bio, Inc. | — | $93M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jason AndersonDirector
- Carlos BustamanteDirector
- J.Taylor CrandallDirector
- J. Taylor CrandallDirector
- Todd DickinsonDirector
- Mathew EasterdayExecutive Officer
- Ed GreenDirector
- Gregory LucierDirector
- Christopher McDonielExecutive Officer
- Edward SchulakDirector · Executive Officer
- David SinclairDirector
- Christopher WibblemanDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.